1) 河南省科技厅, 河南省重点研发与推广专项（科技攻关）, 抗耐药的微管蛋白秋水仙碱结位点抑制剂的设计、合成与生物活性研究, 212102310316, 10万元, 2021.01-2022.12, 主持, 结题。

2) 河南省教育厅, 河南省高等学校重点科研项目计划（2024年度河南省高等学校重点科研项目）, 微管秋水仙碱位点/mTOR双重抑制剂的设计、合成及对耐药非小细胞肺癌活性研究, 24A350001, 3万元, 2024.01-2025.12, 主持, 在研。

3)河南省科技厅, 河南省重点研发与推广专项（科技攻关）, 新型脲基类铁死亡/自噬双重诱导剂的设计、合成与抗肿瘤分子机制研究, 242102310439, 2024.01-2025.12, 主持, 在研。

1) Liang Tingting1; Dong Haiyang1; Wang Zhuangzhuang; Lu Lu; Song Xueting; Qi Jianguo; Zhang Yahong*; Wang Jianhong*; Du Guanhua*. Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment. Eur. J. Med. Chem., 2024, 268: 116277.

2) Lu Lu; Li Keke; Pu Jiaxin; Wang Shaochi; Liang Tingting*; Wang Jianhong*. Dual-Target Inhibitors of Colchicine Binding Site for Cancer Treatment. Eur. J. Med. Chem., 2024, 116543.

3) Niu Linqiang; Cao Qijuan; Zhang Tian; Zhang Yahong; Liang Tingting^*; Wang Jianhong^*. Simultaneous detection of mitochondrial viscosity and peroxynitrite in livers from subjects with drug-induced fatty liver disease using a novel fluorescent probe. Talanta, 2023, 260: 124591.

4) Liang Tingting^1,*; Lu Lu¹; Song Xueting; Qi Jianguo; Wang Jianhong^*. Combination of microtubule targeting agents with other antineoplastics for cancer treatment. Biochim. Biophys. Acta, Rev. Cancer, 2022, 1877: 188777.

5) Niu Linqiang; Zhang Tian; Zhao Haoran; Dong Haiyang; Zhang Yahong; Liang Tingting^*; Wang Jianhong^*. Simultaneous imaging of cysteine and viscosity in living cells with sharp contrast fluorescence between red and green by a dual-responsive fluorescence probe. Dyes Pigm., 2022, 206: 110610.